Two cases could trigger dramatic changes in the way medications and therapies are regulated.
regulation
Arsenic, Chicken and Old Regulatory Standards
Now, before, I get started on this post, I want everyone to take a deep breath. O.K.? So it turns out that a common drug given to chickens — 3-Nitro, also known as Roxarsone — contains arsenic. You know, arsenic, that popular …
Want to Reduce Your Exposure to BPA? Cut Out Canned, Packaged Foods
(Updated) There’s a lot we don’t know about bisphenol-A (BPA), a common chemical used in food packaging and polycarbonate plastics that may also mess with hormones.
Study: Even “BPA-Free” Plastics Leach Endrocrine-Disrupting Chemicals
Plastics. They seem so…inert. Slow to erode or decay, with a biodegradation time measured in the hundreds of years, plastics appear cut off from the organic environment in the way that no other product is, safe and secure and sterile.
Flame Retardants in Everyday Products May Be a Health Hazard, Scientists Say
Here’s a fact to brighten your Thursday: you have a much smaller chance than your grandparents of bursting into flames.
Canada Declares BPA Toxic. Is the U.S. Next?
Yesterday Canada—with very little fanfare—declared the endocrine-disrupting chemical bisphenol-A (BPA) a toxic substance, both to the environment and to public health.
In Illinois, Sex-Offending Doctors Continue Practicing With No Oversight
Sex-offending doctors and health professionals in the state of Illinois have been allowed to continue practicing on probation, virtually unmonitored, according to a long-term investigation by the Chicago Tribune.
FDA: At-Home DNA Tests Should Be Regulated
In early May, national pharmacy chain Walgreens indefinitely delayed sales of an at home genetic test kit after the U.S. Food and Drug Administration said that kit had not been proven safe or effective, and that further inquiry …
An FDA proposal for improved transparency
In a 67-page proposal for a way forward toward more transparency, a U.S. Food and Drug Administration task force suggested broad changes that would increase public access to information about the oversight and regulatory process for everything form pharmaceuticals and food products to medical devices and tanning beds.
